Lexaria Bioscience Corp. (LEXX)
Largest Insider Buys in Sector
LEXX Stock Price History Chart
LEXX Stock Performance
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for …
Insider Activity of Lexaria Bioscience Corp.
Over the last 12 months, insiders at Lexaria Bioscience Corp. have bought $5,008 and sold $10,268 worth of Lexaria Bioscience Corp. stock.
On average, over the past 5 years, insiders at Lexaria Bioscience Corp. have bought $43,963 and sold $10,268 worth of stock each year.
Highest buying activity among insiders over the last 12 months: TURKEL CATHERINE C. (director) — $10,016.
The last purchase of 1,600 shares for transaction amount of $5,008 was made by TURKEL CATHERINE C. (director) on 2024‑08‑12.
List of Insider Buy and Sell Transactions, Lexaria Bioscience Corp.
| 2024-08-12 | director | 1,600 0.0097% | $3.13 | $5,008 | -0.92% | |||
| 2024-07-31 | Sale | Secretary | 2,567 0.0177% | $4.00 | $10,268 | -0.50% | ||
| 2023-02-09 | director | 1,500 0.0253% | $2.84 | $4,267 | -55.56% | |||
| 2022-10-14 | Chief Financial Officer | 121 0.002% | $2.09 | $253 | +2.37% | |||
| 2022-10-13 | Chief Executive Officer | 16,600 0.275% | $2.10 | $34,860 | +0.94% | |||
| 2022-10-12 | Chief Executive Officer | 21,900 0.3658% | $1.99 | $43,537 | +7.25% | |||
| 2018-05-30 | Sale | 47,900 0.0843% | $1.90 | $91,011 |
Insider Historical Profitability
| TURKEL CATHERINE C. | director | 3100 0.0196% | $2.97 | 2 | 0 | <0.0001% |
| BUNKA CHRISTOPHER | Chief Executive Officer | 254412 1.6092% | $2.97 | 2 | 0 | +4.09% |
| Downey Gregory | Chief Financial Officer | 1954 0.0124% | $2.97 | 1 | 0 | +2.37% |